Imaging, biodistribution and therapy potential of Halogenated tamoxifen analogues

This publication has 14 references indexed in Scilit:

• Halogenated Analogues of Tamoxifen: Synthesis, Receptor Assay, and Inhibition of MCF7 Cells
  Journal of Pharmaceutical Sciences, 1992
• The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen
  Cancer, 1991
• Synthesis and in Vitro Receptor Binding Studies of Fluorotamoxifen Analogues
  Pharmaceutical Research, 1991
• Estrogen-Receptor-Negative Breast Cancer Tissue Is Chemosensitive in vitro Compared with Estrogen-Receptor-Positive Tissue
  European Surgical Research, 1990
• Direct incorporation of [¹¹C]carbon dioxide for labeling bioactive molecules. An application to [¹¹C] labeled tamoxifen
  Journal of Labelled Compounds and Radiopharmaceuticals, 1989
• 21-[18F]fluoro-16.alpha.-ethyl-19-norprogesterone. Synthesis and target tissue selective uptake of a progestin receptor-based radiotracer for positron emission tomography
  Journal of Medicinal Chemistry, 1988
• A new triphenylethylene compound, Fc-1157a
  Cancer Chemotherapy and Pharmacology, 1986
• Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent
  Journal of Medicinal Chemistry, 1985
• Activated oestrogen receptors in breast cancer and response to endocrine therapy
  European Journal of Cancer and Clinical Oncology, 1984
• Tissue distribution of the radiolabeled antiestrogen [125I]iodotamoxifen
  International Journal of Nuclear Medicine and Biology, 1982